TPN171

Overview

TPN171 is a potent, selective and oral bioavailable inhibitor of phosphodiesterase type 5 ( PDE5 ) with an IC 50 of 0.62 nM, being developed for the treatment of pulmonary arterial hypertension (PAH).

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Colorectal Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Phosphodiesterase (PDE)

Product Information

• Catalog No.: HY-128593
• CAS No.: 1229018-87-4
• Molecular Formula: C24H35N5O3
• Molecular Weight: 441.57
• Purity: 98.10%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 1 mg/mL (2.26 mM); Clear solution
• Availability: In-stock

Source

Original product source